A Single Dose of a DNA Vaccine Encoding Apa Coencapsulated with 6,6=-Trehalose Dimycolate in Microspheres Confers Long-Term Protection against Tuberculosis in Mycobacterium bovis BCG-Primed Mice

Carlétti, Dyego; Fonseca, Denise Morais da; Gembre, Ana Flavia; Masson, Ana Paula; Campos, Lívia Weijenborg; Leite, Luciana C. C.; Pires, Andréa Rodrigues; Vieira, Joseli Lannes; Silva, Célio Lopes; Bonato, Vânia Luiza Deperon; Horn, Cynthia.
Artículo en Inglés | ARCA | ID: arc-11676

Documentos relacionados

  1. Comparative transcriptomics reveals common and strain-specific responses of human macrophages to infection with Mycobacterium tuberculosis and Mycobacterium bovis BCG.
  2. Intravenous BCG Vaccination of Diversity Outbred Mice Results in Moderately Enhanced Protection against Challenge with Mycobacterium tuberculosis Compared to Intradermal Vaccination.
  3. IL-10 Receptor Blockade Delivered Simultaneously with Bacillus Calmette-Guérin Vaccination Sustains Long-Term Protection against <i>Mycobacterium tuberculosis</i> Infection in Mice.
  4. BCG-induced trained immunity: history, mechanisms and potential applications.
  5. First insight into the whole-genome sequence variations in Mycobacterium bovis BCG-1 (Russia) vaccine seed lots and their progeny clinical isolates from children with BCG-induced adverse events.
  6. Genome sequences of BCG Pasteur ATCC 35734 and its derivative, the vaccine candidate BCG&#916;BCG1419c.
  7. Controlled Human Infection Models: Is it Really Feasible to Give People Tuberculosis?
  8. Activation dynamics of antigen presenting cells in vivo against Mycobacterium bovis BCG in different immunized route.
  9. Deletion of BCG_2432c from the Bacillus Calmette-Guérin vaccine enhances autophagy-mediated immunity against tuberculosis.
  10. Bacillus Calmette-Guérin Skin Reaction Predicts Enhanced Mycobacteria-Specific T-Cell Responses in Infants: A <i>Post Hoc</i> Analysis of a Randomized Controlled Trial.